Affinity DataEC50: 2.00E+3nMAssay Description:Thermal stabilization of recombinant METTL3 (354 to 580 residues) (unknown origin) expressed in HEK293T cells assessed as non-aggregated METTL3-ePL p...More data for this Ligand-Target Pair
Affinity DataEC50: 850nMAssay Description:Thermal stabilization of endogenously expressing full length METTL3 in human MOLM-13 cells assessed as stabilized METTL3 incubated for at 54 degC by ...More data for this Ligand-Target Pair
Affinity DataKd: 4.80nMAssay Description:Binding affinity to METTL3 (unknown origin) assessed as dissociation constant by SPR analysisMore data for this Ligand-Target Pair
Affinity DataKd: 1.40nMAssay Description:Binding affinity to METTL3 (unknown origin) by SPR methodMore data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 3.84nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
Affinity DataIC50: 5nMAssay Description:Inhibition of recombinant METLL3 (unknown origin) expressed in baculovirus infected Sf9 cells assessed as decrease in N6-methyladenosine level in oli...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
TargetN6-adenosine-methyltransferase catalytic/non-catalytic subunit(Human)
Storm Therapeutics
US Patent
Storm Therapeutics
US Patent
Affinity DataIC50: 6.10nMAssay Description:The enzymatic assay was established to determine IC50 values for inhibition of RNA methyltransferase activity. The enzyme used was full-length his-ta...More data for this Ligand-Target Pair
